Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
University of South California, Los Angeles, California University of California Los Angeles, Los Angeles, California Stanford University Medical Center, Stanford, California AdventHealth Celebration, Celebration, Florida Emory Healthcare, Emory Clinic, Atlanta, Georgia Massachusetts General Hospital, Boston, Massachusetts Karmanos Cancer Institute, Detroit, Michigan Hackensack University Medical Center, Hackensack, New Jersey New York University Medical Oncology Associates, New York, New York Icahn School of Medicine at Mount Sinai, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York The Ohio State University Comprehensive Cancer Center, Columbus, Ohio Tennessee Oncology, PLLC, Nashville, Tennessee The University of Texas MD Anderson Cancer Center, Houston, Texas